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Abstract.  Fibroblast growth factor receptors (FGFRs) 
are encoded by at least four distinct highly conserved 
genes, and alternative  splicing generates multiple gene 
products.  The close relationship among different 
FGFRs has greatly increased the difficulty in generat- 
ing specific immunochemical probes. As an alternative 
strategy, we constructed a fusion protein comprising 
keratinocyte growth factor (KGF) and an IgGt Fc do- 
main (HFc). The chimeric molecule was efficiently 
secreted from transfectants as a disulfide-linked dimer 
that bound KGFRs with high affinity.  Moreover, the 
KGF-HFc, like native KGF, induced DNA synthesis by 
epithelial cells implying normal  functional receptor 
activation.  Because it retained the convenient detection 
properties of an immunoglobulin,  it was possible to 
use the KGF-HFc in ligand-mediated histochemical 
analysis of KGFRs. Flow cytometry revealed KGFoHFc 
chimera detection of the KGFR, an alternative FGFR2 
product, but not FGFR1 (fig) or FGFR2 (bek).  His- 
tochemical analysis of normal skin demonstrated the 
specific localization of KGFRs within the spinous 
layer,  a zone of epithelial cell differentiation.  KGFRs 
were also localized to epithelial cells within a  specific 
region of the hair follicle, and they were not detect- 
able in cells of the sweat gland.  Tissue sections of soft 
palate and tonsil, two examples of nonkeratinizing  epi- 
thelium,  revealed staining of stratum spinosum and 
some staining  of the basal cell layer as well.  Neither 
salivary gland epithelium nor lymphoid cells were 
positive. The ciliated epithelium of the trachea ex- 
hibited KGFR expression in intermediate and basal 
cell layers.  In striking contrast to the normal pattern 
of staining  in the adjacent epithelium,  a  squamous cell 
carcinoma of skin lacked detectable KGFP,  s.  Our pres- 
ent findings suggest that growth factor-Ig fusion pro- 
teins may be generally applicable in ligand-mediated 
histochemical detection and localization of growth fac- 
tor receptors. 
ERATINOCYTE growth factor (KGF) L  is a member of 
the FGF family. Originally isolated from human em- 
bryonic fibroblast conditioned  medium, KGF is ex- 
pressed by stromal fibroblasts of many epithelial tissues, and 
it is unique among FGF family members in its epithelial cell 
target specificity  (Rubin  et al.,  1989; Finch  et al.,  1989). 
During wound healing, KGF mRNA expression is dramati- 
cally increased  in  comparison  to that  of the other  FGFs 
(Werner  et al.,  1992a).  Additionally,  KGF appears to play 
an important  role as a paracrine effector in the development 
and differentiation  of a variety of epithelial  tissues (Werner 
et al.,  1992b; Marchese et al.,  1990; Alarid et al.,  1994). 
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KGF binds and  activates  the KGF receptor (KGFR), a 
membrane-spanning  tyrosine kinase generated by alternative 
splicing of FGFR2 (one of four members of the FGF recep- 
tor  [FGFR]  family).  The  FGFR extracellular  domain  is 
comprised oflg-like domains. By analysis of a series of natu- 
rally occurring FGFR alternative  products, Ig-like domain 
I appears dispensable  for ligand binding (Miki et al., 1991). 
Additional gene products arise from the alternative  splicing 
of the Ig-like domain m-encoded exons, which confer very 
different ligand binding properties (Miki et al.,  1991; Givol 
and  Yayon, 1992;  Fantl  et  al.,  1993).  In  particular,  the 
FGFR2 gene product binds aFGF and bFGF, but not KGF, 
while the alternative  KGFR product binds aFGF and KGF 
at high affinity, but bFGF at much lower affinity (Bottaro et 
al.,  1990; Yayon et al.,  1992). 
The nearly identical nature of the KGFR and FGFR2 iso- 
forms has made it difficult to develop specific immunochem- 
ical probes with which to elucidate patterns  of receptor dis- 
tribution  and expression.  To overcome these obstacles, we 
engineered a chimeric molecule between cDNAs encoding 
KGF and the immunoglobulin  G  Fc domain.  Our results 
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the development of highly  specific  probes  for cell  surface 
receptors and in targeting molecules to intracellular sites of 
specific  cell  populations. 
Materials and Methods 
Construction of  Recombinants 
The region encoding the hinge, CH2, and CH3 domains (HFc) of a eDNA 
(LaRochelle,  W.  J.,  unpublished  observation)  for  the  mAb sis  I  (LaRochelle 
et  al.,  1989)  heavy  chain  was  amplified  by  the  PCR (Cetus  Corp.,  Norwalk, 
CT) so  as  to  contain  an  Xhol-cloning  site  5'  and  in  frame  with  the  HFc PCR 
product, as well  as BamHl sites  at both termini.  BamHI restriction  en- 
donucleasc  digestion  of  the  HFc PCR product  and  ligation  into  the  BamHI 
site  of  the  pUCI8 plasmid cloning  vector  created  pUCIS-HFc. The  BamHI 
excision  sites  of  pUC 18-HFc allowed  insertion  of  the  HFc cDNA into  the 
BglII  site  of  the  MMTnco plasmid  (LaRochclle  et  al.,  1990)  resulting  in  the 
MMTneo-HFc expression  vector  (Fig.  I).  A second  vector,  MMTnco-spHFc, 
was generated  by adding  the  PDGF  A signal  peptide  (sp)  upstream and in 
frame with  the Xhol-cloning site  of MMTneo-HFc.  The KGF-cncoded 
cDNA (Finch  et  al.,  1989)  minus  the  stop  codon  was  amplified  with  Xhol- 
or SalI-compatible  ends by PCR, digested with the appropriate restriction 
enzyme and cloned in frame with the HFc eDNA of MMTnco-HFc. 
Transfection and Analysis of  KGF-HFc Expression 
Plasmid DNA from the KGF-HFc MMTneo construct was transfected into 
NIH 3T3 ceils by the calcium phosphate precipitation technique (Wiglet et 
al.,  1977).  Colony  formation after selection  in G418-contalning  medium 
was used as an internal marker of transfection  efficiency. 
KGF-HFc  transfectants  were  washed  and  incubated  for  30  rain  in 
methionine- and cysteine-free  DME containing 25 #M zinc chloride fol- 
lowed  by  metabolic  labeling  with  [35S]methionine  (125  ~Ci/mi)  and 
[3SS]cysteine  (125 #Ci/ml) for 3.5 h. After collection,  conditioned  medium 
was immunoprecipitated with a KGF monoclonal antibody 1G4 (Alarid et 
al., 1994) or anti-mouse Fc (Pierce-Chemical Co., Rockford, IL ) followed 
by Staphylococcus aureus protein A-Sepharose CL-4B. The immunoprecip- 
itated  proteins were  then resolved  by  SDS-PAGE  and  visualized  after 
fluorography. 
Ligand-binding Assay 
32D cells are an IL-3-dependent hematopoietic cell line that do not nor- 
really express KGFRs. An expression vector containing the KGFR was in- 
troduced  into naive 32D  cells by  electroporation and  marker  selected 
(Pierce, J. H., unpublished  observation). 32D cell KGFR transfectants were 
harvested by centrifugation,  washed in DME, and gently  resuspended  in 
binding buffer (DME, 25 mM Hepes, pH 7.4,  1 mg/rnl BSA, and 1 ~g/mi 
heparin). To this cell suspension was added increasing concentrations of un- 
labeled KGF-HF,  c,  enriched by protein A  chromatography,  as well  as a 
saturating amount of 125I-KGF (2 ng) prepared by our standard iodination 
protocol (Bottaro et al.,  1990; Ron et al.,  1993 ) in binding buffer. After 
1 h at 16°C, the cell suspension was layered onto 300/zl of a chilled oil 
mix (n-butyl phthalate [Fischer Scientific, Pittsburgh, PA]/bis (2-ethylhexyl) 
phthalate 1.5:1 (Eastman Kodak  Co.,  Rochester,  NY).  Cells were cen- 
trifuged in an Eppendorf microfuge at I0K for 10 rain at 4°C. The cell pellet 
was removed and counted in a gamma counter (model 5500; Beckman In- 
struments, Inc., Fullerton, CA). 
Mitogenic Assay 
Thymidine incorporation into BALB/MK cells was performed as described 
(Rubin et al.,  1989; Ron et al.,  1993).  Briefly, varying concentrations of 
recombinant KGF (Ron et al.,  1993 ) or KGF-HFc protein were added to 
quiescent cultures.  Cells were incubated at 37°C  for  16 h,  followed by 
[3H]thymidine  addition  for  5  h.  Cells  were  washed,  harvested,  and 
[3H]thymidine  uptake was  measured by liquid scintillation counting.  In 
some cases,  a KGF-neutralizing  monoclonal antibody or heparin (Sigma 
Chemical Co.,  St.  Louis,  MO)  was  added to  mitogenically  equivalent 
amounts of KGF or KGF-HFc. 
Flow Cytometric Analysis 
NIH 3T3 cells were transfected  with either the KGFR,  FGFR2 (lack), or 
FGFR1 (fig) by standard calcium phosphate precipitation technique (Wigler 
et  al.,  1977).  Similar levels  of each receptor were  expressed  by each 
marker-selected  cell population (Bonam, D. P., unpublished observation). 
B5-589 cells or NIH 3T3 cells transfected with either the KGFR,  FGFR2 
(bek), or FGFR1  (fig) were removed  from 10-cm culture dishes with 1% 
EDTA, PBS, pH 7.4, pelleted,  and incubated for 10 rain at room tempera- 
ture in DME, 10  % fetal calf serum, 0. 5 % milk, 0.01% Twcen 20, and 0.3 M 
NaCI  to  block nonspecific  binding. The  cells were  again pelleted  and 
resuspended in conditioned medium from KGF-HFc or control HFc trans- 
fectants adjusted to 0.5% milk, 0.01% Twccn 20, 0.3 M NaCI, and 10 mM 
Figure 1. Engineering a KGF-HFc chimera. (A) The KGF-encoded 
eDNA minus its stop codon was recombined with the HFc portion 
of the  mouse  immunoglobulin IgGt  heavy  chain  eDNA  at  the 
hinge region as described in Materials and Methods. (B) eDNA se- 
quence  and encoded  amino acid  residues  adjacent to the XhoI- 
cloning site of MMTneo HFc are shown. (C) The HFc portion of 
the immunoglobulin heavy chain gene was subjected to the poly- 
merase  chain  reaction to  generate  BamHI-compatible ends and 
cloned into pUC 18. The HFc PCR product also contained an XhoI- 
cloning site introduced by PCR 5' and in frame with the Fc domain, 
but downstream of the 5' BamHI site.  The HFc fragment was re- 
moved from pUC18 by BamHI restriction endonuclease digestion, 
and it was cloned into the BglU site of the MMTneo vector. The 
KGF  eDNA  was  amplified  by  PCR  with  SalI-compatible  ends, 
digested with 'restriction enzyme, and ligated into the XhoI site of 
the MMTneo HFc vector in frame with the Fc domain. 
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with PBS, pH 7.4, 0.01% Tween 20. Bound primary antibody was detected 
after  incubation for  10 min with FITC-conjugated goat anti-mouse IgG 
(Biosource International,  Camarillo,  CA) diluted  1/100 in  DME,  0.5% 
milk, 0.01% Tween 20, and  10 mM sodium benzoate. Cells were washed 
twice with PBS, pH 7.4, 0.01% Tween 20, resuspended in 600 ~tl of Haema- 
line and processed using a FACSCAN  TM  analyzer (Becton Dickinson Im- 
munocytometry Systems, Mountain View, CA) (Ashmun et al.,  1989). 
Ligand-mediated Histochemistry 
Ligand-mediated histochemistry was performed on frozen sections of hu- 
man skin fixed in 1% acetone/1.0 mM trichloroacetic acid/ethanol for 2 rain, 
then transferred to 100% ethanol, followed by 50% ethanol, and then PBS, 
pH 7.4. Slides were treated in PBS, pH 7.4, 1.5 M NaC1 for 30 rain, then 
washed in PBS, pH 7.4. The sections were blocked for 1 h at room tempera- 
ture with 5.0% Milk, 0.1% Tween 20, and PBS, pH 7.4, which was previ- 
ously cleared by centrifugation at 20,000 g for 20 rain. The slides were then 
incubated with KGF-HFc or control HFc-conditioned  medium adjusted to 
5.0% milk, 0.01% Tween 20, 0.3 M NaC1, and 10 mM sodium benzoate for 
1 h at room temperature followed by three washes with PBS, pH 7.4, 0.01% 
Tween 20.  The sections were then treated  with rabbit  anti-mouse IgG~ 
conjugated to horseradish  peroxidase  (Boehringer Mannheim Biochemi- 
eals, Indianapolis, IN) diluted 1/100 in DME, 5.0% milk, 0.01% Tween 20, 
and  10 mM sodium benzoate for 1 h. The slides were then washed three 
times in PBS, pH 7.4, 0.01% Tween 20 and three times in PBS, pH 7.4. The 
color reaction was performed as described (Harlow and lane, 1988) using 
diamino  banzidine  tetrachloride  (DAB) according  to the manufacturer's 
protocol (Pierce). In some experiments, the ImmunoPure DAB substrate kit 
(Pierce) was used according to the manufacturer's protocol. Similar protein 
levels of  KGF-HF'c  or control HFc were used in ligand-mediated histoehem- 
ical experiments. However, the control HFc showed no staining of tissue 
sections, even at a  10-fold higher concentration than KGF-HFc. 
In Situ Hybridization 
In situ hybridization was performed on deparattinized tissue sections essen- 
tially as described (Wilkinson et al.,  1987), using 33p-labeled  probes at a 
concentration of  0.2 ng/ml per kb length of  cloned fragment in hybridization 
buffer (50% deionized formamide, 0.3 M NaCI, 20 mM Tris HCI, pH 8.0, 
5 mM EDTA, 10% Dextran sulfate, 1×  Denhardt's buffer, and 0.5 mg/ml 
yeast RNA). Tissue sections were hybridized at 55°C for 16-18 h and then 
washed under high stringency conditions (2× SSC and 50% formamide at 
65°C) for 30 rain. Nonhybridized probe was digested with 20 mg/ml RNase 
A for 30 rain at 37"C. After further washing under high stringency condi- 
tions, slides were dehydrated through graded alcohols containing 0.3 M am- 
monium acetate. Sections were dipped in NTB-2 emulsion (Kodak), diluted 
1:1 in water, air dried, and stored desiccated at 4*C. After appropriate ex- 
posure times, slides were developed in Kodak D-19 developer and counter- 
stained with 0.02  % toluidine blue. 
Thus, we reasoned that deletion of the variable and CH1 do- 
mains from the heavy chain would facilitate dimer secretion 
and that grafting KGF to the random structure of the hinge 
would allow maximal adaptability consistent with presenta- 
tion of growth factor biologic function. 
To engineer the HFc expression construct, we exploited 
the  polymerase  chain  reaction  to  generate  BamHI-com- 
patible  ends  on  the  HFc portion  of the  immunoglobulin 
heavy chain eDNA that was  subsequently cloned into the 
BamHI site of pUC 18. The HFc eDNA insert was also en- 
gineered to contain an XhoI-cloning site in frame and 5' to 
the HFc region, but within the BamHI sites (Fig. 1). The HFc 
fragment was removed from pUC18-HFc by BamHI diges- 
tion and cloned into the BgllI site of the MMTneo vector. 
The KGF coding sequence was then amplified by PCR with 
either XhoI-  or  SalI-compatible ends,  restriction enzyme 
digested,  and  subcloned into the MMTneo HFc vector in 
frame with the IgG HFc domain (Fig.  1). 
KGF-HFc Chimeric Gene Product Possesses Both KGF 
and lgGl Fc Domain Determinants 
The KGF-HFc construct was transfected into NIH 3T3 cells 
to investigate the immunochemical and biochemical proper- 
ties of the encoded product. Marker selected mass cultures 
were  radiolabeled with  [35S]methionine  and  psS]cysteine. 
Although protein A alone detected the chimeric gene prod- 
uct in culture fluids, the signal was '~15- to 20-fold greater 
when protein A was used with either KGF monoclonal anti- 
body or anti-mouse Fc (data not shown). To establish that 
KGF-HFc possessed the immunochemical determinants of 
KGF, culture fluids were collected and incubated with a KGF 
Results 
Strategy for KGF-HFc Chimera Construction 
In an effort to generate a high affinity KGFR-specific probe 
with the well-characterized detection properties of an immu- 
noglobulin, we designed a chimera in which the KGF eDNA 
was recombined with the HFc portion of  the mouse immuno- 
globulin IgG~ heavy chain eDNA at the hinge region (Fig. 
1).  Inherent difficulties with this  approach  included poor 
secretion and rapid degradation of the heavy chain in the ab- 
sence of the partner light chain, respectively (Capon et al., 
1989). However, Cogne and co-workers reported thiit struc- 
turally abnormal  heavy chains,  containing only CH2  and 
CH3 domains, were efficiently secreted apparently because 
of the deletion of the CH1 domain (Cogne et al., 1992). Ad- 
ditionally, the flexibility and adaptability of the hinge region 
of the heavy chain was well documented (Burton,  1985). 
Figure 2. Immunochemical analysis of KGF-HFc chimera. Meta- 
bolically labeled conditioned medium from mock (lanes 1 and 3) 
or KGF-HFc MMTneo (lanes 2 and 4) transfectants was immuno- 
precipitated with anti-KGF monoclonal antibody (lanes I and 2) or 
anti-mouse Fc antibody (lanes 3 and 4), as described in Materials 
and  Methods. Immunoprecipitates  were  recovered with protein 
A-Sepharose,  subjected to SDS-PAGE, and the immunoreactive 
species were visualized after fluorography. 
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Figure 3. Comparison of KGF-HFc and KGF biologic activity.  (A) 
The biologic activity of the KGF-HFc ([3) or KGF (o) was mea- 
sured on quiescent BALB/MK ceils. Cells were first incubated with 
the indicated concentration of chimeric gene product or growth fac- 
tor. After 16 h at 37°C,  [3H]thymidine  was added for 5 h.  Cells 
were then washed, harvested, and [3H]thymidine  uptake was mea- 
sured  by  liquid  scintillation  counting.  In  some  cases,  a  KGF- 
neutralizing monoclonal antibody (closed symbols) was added to 
confirm the specificity of either the KGF-HFc (m) or KGF (o). (B) 
Quiescent BALB/MK ceils were incubated with the indicated con- 
centration of heparin followed by addition of mitogenically equiva- 
lent amounts of either KGF-HFc ([]) or KGF (o), as described in 
Materials and Methods. 
monoclonal antibody followed by immunoprecipitation with 
protein A-Sepharose. As shown in Fig. 2, three distinct p94- 
98 immunoreactive species were observed. When the condi- 
tioned medium was incubated instead with anti-mouse IgG 
Fc, the same p94-98 species were observed (Fig. 2). In con- 
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Figure 4. Flow cytometric analysis of KGF-HFc binding to mem- 
bers of the FGFR superfamily. KGF-HFc was incubated with B5- 
589 cells (. • .) or NIH 3T3 cells transfected with the KGFR ( ...... ), 
bek (- - -), or fig (  ..... ), and it was subjected to flow cytometric 
analysis, as described in Materials and Methods. As an additional 
control, untransfected NIH 3T3 cells showed background staining 
comparable to bek and fig. Furthermore, the control HFc domain 
of the parental IgG did not recognize B5-589 or NIH 3T3 KGFR 
transfectants (data not shown). Bound KGF-HFc was detected with 
FITC-conjugated rabbit anti-mouse IgG. Cells were processed as 
described (LaRochelle et al., 1993) using a FACSCAN  TM analyzer. 
trast, these species were not found in immunoprecipitates of 
conditioned  medium from control  MMTneo transfectants. 
Since KGF-HFc possessed the IgGt heavy chain hinge re- 
gion known to cause IgG dimer formation, we sought to de- 
termine whether KGF-HFc was a disulfide-linked dimer. Ad- 
dition  of 100  mM DTT before SDS-PAGE was associated 
with increased mobility of an apparent 48-kD species after 
immunoprecipitation  with  either  the  KGF  mAb  or  anti- 
mouse HFc (Fig. 2). Thus, this efficiently secreted molecule 
possessed structural determinants of both KGF and the im- 
munoglobulin  Fc domain. 
Functional Properties of the KGF-HFc Chimeric 
Gene Product 
To determine whether the KGF-HFc exhibited KGF biologic 
properties,  we investigated  its ability to induce  [3H]thymi- 
dine uptake in KGF responsive BALB/MK cells.  As shown 
in Fig. 3 A, the KGF-HFc readily stimulated [3H]thymidine 
uptake.  In  comparison  with  recombinant  bacterially  ex- 
pressed  KGF,  which  induced  half-maximal  stimulation  at 
'~10  pM,  the  mammalian  expressed  KGF-HFc  half-max- 
imally stimulated  DNA synthesis at ~,,45  pM.  Thus KGF- 
HFc was comparable to KGF purified from mammalian cells 
which  is also fivefold lower in mitogenic activity than the 
bacterial recombinant ligand (Ron et al.,  1993).  DNA syn- 
thesis induced by the chimera was inhibited by >75 %  by a 
KGF-neutraiizing  monoclonai  antibody,  demonstrating  the 
KGF specificity of the mitogenic activity. As additional con- 
trols,  neither the secreted HFc portion of IgG, nor control 
IgGt  monoclonal  antibody  induced  detectable  [3H]thymi- 
dine uptake (data not shown). 
Functional properties of KGF include its ability to interact 
with  heparin,  which  dramatically  inhibited  KGF  induced 
The Journal  of Cell  Biology,  Volume 129,  1995  360 Figure 5. Ligand-mediated histochemical analysis of KGFR expression in human epidermis. KGFR expression was probed with KGF-HFc 
(A-C) or control HFc (D) on tissue sections from normal human skin. KGF-HFc was detected with rabbit anti-mouse IgGt conjugated 
to horseradish peroxidase, as described in Materials and Methods. KGFR was localized to the stratum spinosurn of normal epidermis (A) 
and the bulb region of the hair follicle (B). The stratum basale also stained to a lesser extent. No staining was observed in the upper 
portion of hair follicles (B) or in sweat glands (C). Control HFc showed no staining of the epidermis (D). Bar, 10 #rn. 
proliferation (Bottaro et al.,  1990;  Ron et al.,  1993).  As 
shown in Fig. 3 B, heparin in the range of 1-5 #g,/rrd inhibited 
both KGF-HFc and recombinant KGF to equivalent extents 
of >80%.  In  other  studies,  heparin  Sepharose,  but  not 
Sepharose, precipitated both KGF-HFc and KGF, but had 
no  effect on the  secreted  HFc portion of IgG~ (data  not 
shown).  These findings confirmed that heparin interacted 
specifically with the KGF portion of the chimeric molecule. 
We next compared the ability of KGF-HFc and KGF to 
bind 32D cell transfectants expressing the KGFR by Scatch- 
ard  analysis  (data  not  shown).  KGF-HFc bound  to  32D 
KGFR transfectants with a/G of ,~1.4  nM,  while recom- 
binant KGF possessed a dissociation constant of 0.13  nM. 
Under these conditions, neither molecule detectably bound 
parental 32D cells nor control HFc failed to compete with 
iodinated growth factor binding (data not shown). All of the 
above  results  indicated  that  the  KGF-HFc possessed  the 
KGFR-binding properties and mitogenic signaling functions 
of native KGE 
KGFR-specific Detection by KGF-HFc 
To demonstrate the specificity of KGF-HFc in KGFR im- 
munodetection assays,  we used  flow cytometry. The chi- 
meric molecule was incubated with NIH 3"1"3 cell transfec- 
tants expressing the KGFR, FGFR2 (bek), or FGFR1 (fig), 
as well as B5-589 human breast epithelial cells. As shown 
in Fig. 4, flow cytometry revealed that the KGF-HFc readily 
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mRNA in human epidermis by in 
situ  hybridization.  (,4) Bright- 
field micrograph  of a  toluidine 
blue-stained  tissue  section  of 
normal  human  epidermis.  (B) 
Corresponding dark-field micro- 
graph  demonstrating  hybridiza- 
tion signal for KGFR mRNA in 
the stratum spinosum and basale 
of the epidermis. Bar, 10 ttm. 
recognized the NIH 3T3 KGFR transfectants as indicated by 
the 5- to 10-fold increase in fluorescent intensity compared 
to untransfected NIH 3T3 cells. In contrast, NIH 3T3 trans- 
fectants expressing similar receptor numbers of the alterna- 
tively spliced FGFR2 or FGFR1 showed no increase in stain- 
ing over that of untransfected NIH 3T3 cells. The chimera 
also readily detected B5-589 cells that express ,05  x  104 
KGFRs (Bottaro et al., 1990 ). Under the same conditions, 
the control HFc failed to recognize either B5-589 or the NIH 
3T3  KGFR  transfectants  (data  not  shown).  All  of these 
findings demonstrated the exquisite specificity of KGF-HFc 
in the recognition of the KGFR. 
Ligand-mediated Histochemical Localization of 
KGFRs in Human Epithelium 
The highly specific nature of KGFR recognition by the KGF- 
HFc chimera led us to investigate its application in the local- 
ization of KGFRs in human epithelial tissues.  Thus, cryo- 
preserved sections of human epithelium were incubated with 
the KGF-HFc or control HFc followed by detection with 
anti-mouse  Fc  conjugated to  horseradish  peroxidase.  As 
shown in Fig. 5 A, specific staining with KGF-HFc was ob- 
served within the stratum spinosum of the epithelium and to 
a  lesser extent, the  stratum basale.  Staining  was  uniform 
around the spinous cell surface with no evidence of polarity. 
The stratum corneum and granulosum all lacked detectable 
reactivity under the same conditions. Fig. 5 B demonstrates 
that the bulb region of the hair follicle (Fig. 5 B, left side) 
stained intensely with the KGF-HFc, while the upper portion 
of a hair follicle (Fig. 5 B, right side) did not stain. A typical 
sweat gland, as shown in Fig. 5 C, showed little or no stain- 
ing under these conditions.  As  a  specificity control, HFc 
alone showed no staining (Fig.  5 D). 
The Journal of Cell Biology, Volume 129,  1995  362 Figure 7. Ligand-mediated histochemical analysis of KGFR expression in normal human tissues of the oral cavity. KGFR expression was 
probed with KGF-HFc on tissue sections from normal human soft palate (A and B), tonsil (C), or trachea (D), as described in Materials 
and Methods. (B) KGF-HFc staining of KGFRs of soft palate was detected with DAB-enhanced metal staining. No KGFR staining was 
observed in salivary glands (A), lymphoid tissue (C), or mesenchyme. In each case, control HFc at similar protein concentrations showed 
no staining of tissue sections (data not shown). Bar, 10 tim. 
To provide further evidence for the specificity of the stain- 
ing pattern obtained with the KGF-HFc chimera, we exam- 
ined  the  spatial  expression  of  the  KGFR  transcript  in 
paraffin-embedded sections of normal human skin using in 
situ hybridization. As shown in Fig. 6, KGFR mRNA was 
expressed in both the stratum spinosum and basale of the 
epidermis, but not in the stratum corneum or granulosum. 
Additionally, KGFR mRNA was also detected in hair folli- 
cles (data not shown), in agreement with the pattern of stain- 
ing seen with the KGF-HFc chimera. Control sections hy- 
bridized  with  the  corresponding  sense  strand  transcript 
showed no signal (data not shown). These experiments fur- 
ther demonstrate the specificity of KGF-HFc staining in tis- 
sues that express the KGFR transcript. 
We next investigated the presence of the KGFR in the soft 
palate, an example of nonkeratinizing stratified epithelial tis- 
sue.  As  shown in Fig.  7 A,  the stratum spinosum stained 
most intensely for the KGFR. Of note, KGF-HFc staining of 
salivary  glands  was  not  detectable in  the  same  sections. 
A  metal-enhanced  DAB  reaction showed intense  staining 
throughout the stratum spinosum with weaker staining adja- 
cent to the stratum granulosum and in the basal cell layer 
(Fig.  7  B).  Another nonkeratinizing epithelial tissue,  the 
tonsil (Fig.  7  C) demonstrated KGF-HFc staining of both 
stratum spinosum and basale with little or no KGFR-specific 
staining of the lymphoid cells.  KGFR expression was  also 
studied in the trachea, an example of ciliated cylindrical epi- 
thelial tissue. KGF-HFc was immunoreactive with both the 
intermediate and more basale layers (Fig. 7 D). The salivary 
glands  and  mesenchymal cells  of the  trachea  showed no 
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sion in a human squamous cell carcinoma of  the oral cavity. KGFR 
expression was probed with KGF-HFc on tissue from a squamous 
cell carcinoma, as described in Materials and Methods. Note the 
striking absence of tumor cell KGFR staining, while the adjacent 
epithelium exhibited the normal pattern of KGFR expression. Con- 
trol HFc did not stain (data not shown). Bar, 10 tLm. 
KGF-HFc staining.  The control HFc did not stain any of 
these epithelial tissues under identical conditions (data not 
shown). 
Finally, we investigated KGFR expression in a squamous 
cell carcinoma of the oral cavity. The carcinoma cells were 
entirely devoid of  KGFRs, while the normal pattern of  KGFR 
expression was observed in the adjacent epithelium (Fig. 8). 
Whether the lack of detectable KGFRs represents a general 
pattern for squamous cell carcinoma or provides a marker 
for a particular tumor phenotype remains to be determined. 
In any case, all of the above findings demonstrate the highly 
specific patterns of KGFR expression observed in the differ- 
ent epithelial tissues examined. 
Discussion 
Our present studies describe the application of a growth fac- 
tor Ig fusion protein to the specific immunodetection of cell 
surface receptors. This approach confers particular advan- 
tages where highly related receptors make their discrimina- 
tion very difficult. To our knowledge, there are as yet no 
polyclonal  or  monoclonal  antibodies  that  can  even  dis- 
criminate between the external domains of different mem- 
bers of the FGFR gene family. We demonstrated that the 
KGF-HFc chimera readily detected its cell surface receptor, 
the KGFR, an alternative product of FGFR2, yet did not de- 
tect the FGFR2 despite the fact that these receptors differ 
only within a  small stretch of their respective external do- 
mains (Miki et al., 1991; Givol and Yayon, 1992; Fantl et al., 
1993). The ability to generate such specific immunochemi- 
cal probes in a  systematic manner also obviates the time- 
consuming process of generating and screening monoclonal 
antibodies.  We  demonstrated  further  that  KGF-HFc  ex- 
hibited high receptor affinity and the ability to induce DNA 
synthesis in target cells that express KGFRs. The ability to 
transduce a mitogenic signal contrasts with many monoclo- 
hal antibodies directed against receptors such as those to the 
a-PDGFR or CSF-1R, which bind avidly but do not activate 
receptors (Ashmun et al.,  1989; LaRochelle et al.,  1993). 
The secretory properties of the KGF-HFc chimera were 
such  that  with  the  metallothionein  expression  construct 
used, it was possible to generate quantities only a few fold 
less than that produced from cultured hybridoma cell lines. 
Efficient secretion in part was related to the choice of pro- 
moter in the construct. However, it was likely also caused 
by the deletion of the CH1  domain from the heavy chain. 
There is  evidence that  the normal  heavy chain  is  poorly 
secreted in the absence of light chain (Capon et al.,  1989; 
LaRochelle, W. J., unpublished observations), and there are 
reports that individual heavy chains efficiently secreted dur- 
ing  immunoproliferative disorders  lack  the  CH1  domain 
(Cogne et al., 1992). Functional heavy chain molecules that 
lack the CH1 domain have also been found to be secreted 
in  at  least  one  nonhuman  mammalian  species  (Harners- 
Casterman et al.,  1993). Thus, deletion of the CH1 domain 
may circumvent the need for the light chain partner in heavy 
chain secretion (Capon et al.,  1989).  KGF-HFc secretion 
was  sufficiently robust that it was possible to use culture 
fluids harvested in the absence of further purification for 
KGFR immunodetection. 
Ligand-mediated histochemical staining of skin with the 
KGF-HFc provided the first observations of KGFR expres- 
sion and distribution in an intact tissue. We observed KGFRs 
most intensely in the spinous cell layer directly adjacent to 
the basal  cell layer.  Most  importantly,  correlation of the 
histochemical localization of KGFRs in normal human skin 
by KGF-HFc with the spatial pattern of KGFR mRNA ex- 
pression  detected  by  in  situ  hybridization  demonstrates 
mechanistically that the cellular sites of KGFR transcription 
correspond to the sites of its gene product expression. 
It  has  been  reported  that  keratinocyte proliferation  is 
confined to and defines the basal cell layer (Fuchs,  1990). 
The  spinous  cells ultimately differentiate into the  granu- 
lar cell layer and finally into the stratum corneum.  Thus, 
KGFR staining appears to coincide with cells undergoing 
differentiation in addition to proliferation. We showed that 
KGF-HFc, like KGF itself (Bottaro et al.,  1990; Ron et al., 
1993) directly interacts with heparin. However, several lines 
of evidence suggest that heparan sulfate-like proteoglycans 
were not bound under the conditions that were used. First, 
KGF-HFc immunodetection performed in the presence of 
0.5 M  NaCI eliminated a  broad and weakly diffuse stain- 
ing pattern presumably attributable to the extracellular ma- 
trix heparan  sulfate-like proteoglycans.  Furthermore,  the 
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maximum saturable  staining  implies  the presence  of high 
affinity rather than low affinity binding sites. Finally, the pat- 
tern of staining makes it unlikely  that extraceUular matrix 
components  were  recognized,  since  regions  of epidermis 
known to contain these components, as well as control NIH 
3T3 cell transfectants that secrete heparan sulfate-like pro- 
teoglycans,  were not stained. 
Recent reports have demonstrated the functionality of chi- 
meric receptor proteins fused to immunoglobulins. The use 
of bifunctional  molecules  engineered  as IgG  heavy  chain 
chimeras  was  first  reported  for the  CD4  immunoadherin 
(Capon  et al.,  1989).  Since  then,  receptor-IgG  chimeras 
have been used for structural and functional studies of the 
Ig-like  superfamily  of  receptors  (Williams  and  Barclay, 
1988),  including  the T  cell  antigen  receptor  (Eilat et al., 
1992),  flt3/flk-2  (Lyman  et  al.,  1993),  c-kit  (Liu  et  al., 
1993), the 3 PDGFR (Heidaran et al.,  1995), and the KGFR 
(Cheon et al.,  1994). In the case of the KGFR, this approach 
provided a framework for dissection of its ligand-binding do- 
mains and made it possible to demonstrate that high affinity 
binding sites for two high affinity ligands,  aFGF and KGE 
reside  within different receptor Ig-like domains (Cheon et 
al.,  1994).  The  ligand  binding  properties  of other  non- 
Ig-like  receptors,  including  the  natriuretic  peptide  recep- 
tors (Bennett et al.,  1991),  tumor necrosis factor receptor 
(Howard et al.,  1993), and hepatocyte growth factor recep- 
::or (Mark et al.,  1992) have also been analyzed by means 
of immunoglobulin fusion proteins. 
Growth factor immunoglobulin chimeras have been much 
less actively investigated.  In one report, IGF-1  was grafted 
to the carboxyl terminus of the IgG heavy chain (Shin and 
Morrison,  1990).  This resulted in a poorly secreted mole- 
cule with markedly impaired receptor-binding properties. In 
another study, IL-2 fused to the immunoglobulin CH1  do- 
main demonstrated high affinity receptor binding and mito- 
genic  activity,  but  it  was  not  tested  in  ligand-mediated 
histochemical  assays (Landolfi,  1991).  Our present results 
suggest that growth factor-Ig  fusion proteins generated  as 
described here can be used to define the expression and dis- 
tribution of specific receptors in histologic specimens.  It is 
known that certain  growth  factor receptors  can be abnor- 
mally  upregulated in tumor cells  (Aaronson,  1991).  Thus, 
such probes may prove useful in diagnosis and prognosis of 
malignancies and other pathologic states. This approach has 
the potential of identifying novel target cells and novel recep- 
tors for known growth factors. Finally, the ability of growth 
factor Ig fusion proteins to cause functional receptor activa- 
tion  suggests  normal  receptor  processing  associated  with 
downregulation  and  internalization.  If  so,  such  chimeric 
ligands may provide ideal vehicles for delivering toxins and 
other therapeutic modalities to intracellular sites in specific 
target cell populations. 
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